FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087540 [Registered on: 26/05/2025] Trial Registered Prospectively
Last Modified On: 24/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Efficacy Of Kushthadi Ointment In The Management Of Post Operative Fistulectomy Wound compared to Povidone Iodine 
Scientific Title of Study   A Randomized Controlled Clinical Trial To Evaluate The Efficacy Of Kushthadi Ointment In The Management Of Post Operative Fistulectomy Wound As Compared With Povidone Iodine 10 percent Ointment 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sunil Dhavale 
Designation  Ph. D. Scholar 
Affiliation  Yerala Medical Trust Ayurveda mahavidyalaya 
Address  Shalya Tantra OPD No. 2, Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210.

Thane
MAHARASHTRA
410210
India 
Phone  9221528099  
Fax    
Email  m2d2810@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunil Dhavale 
Designation  Ph. D. Scholar 
Affiliation  Yerala Medical Trust Ayurveda mahavidyalaya 
Address  Shalya Tantra OPD No. 2, Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210.

Thane
MAHARASHTRA
410210
India 
Phone  9221528099  
Fax    
Email  m2d2810@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjeev Yadav 
Designation  Principal and Professor 
Affiliation  erala Medical Trust Ayurveda mahavidyalaya 
Address  Shalya Tantra OPD No. 2, Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210.

Thane
MAHARASHTRA
410210
India 
Phone  9322456999  
Fax    
Email  drsanjeevyadav22@gmail.com  
 
Source of Monetary or Material Support  
Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210. 
 
Primary Sponsor  
Name  Dr Sunil Dhavale 
Address  Dr. Sunil Dhavale Shalya Tantra OPD, Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sunil Dhavale  Yerala Medical Trust Ayurveda Mahavidyalaya  Shalya Tantra OPD, Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210. Shalya Tantra OPD, Yerala Medical Trust Ayurveda mahavidyalaya, Sector - 4, Kharghar, Navi Mumbai - 410210.
Thane
MAHARASHTRA 
09221528099

m2d2810@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee for Research, Dr. G. D. Pol Foundations Institute for Research and Post graduate Studies in Ayurveda, Kharghar, Navi Mumbai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K605||Anorectal fistula. Ayurveda Condition: BAGANDARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kushthadi Churna - Ointment, Reference: Sushruta Samhita Chikitsa Sthana - Bhagandara Chikitsa, Route: Topical, Dosage Form: Malahara/ Ointment/ Balm, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-Povidone IodinePOVIDONE IODINE 10% Ointment application - Twice a day - 28 days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Adult of any gender
All post-operative fistulectomy wound 
 
ExclusionCriteria 
Details  1. Wound involved with TB, malignancy
2. Infections like HIV, HbsAg Syphilis
3. Uncontrolled Diabetic wound 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
- Assessment of Relief in symptoms of Bhagandara such as Shool, Strava, Shotha, Sparshasahatva and gandha   - Baseline, Day 7, Day 14, Day 21 and Day 28 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   09/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Two arm, Open labeled, randomized comparative clinical study
Study setting- Clinical study Selection of patients-
Selection of Patients from the IPD and OPD of the concern Institute fulfilling POST OPERATIVE FISTULECTOMY WOUND will be done as per inclusion and assessment criteria from OPD will be enrolled in this study.
There will be 70 number of patients either gender from ShalyaTantra OPD/IPD of concerned institute, divided into 2 groups
Groping of patients-
1) Study group : 35 Patients.
2) Control group : 35 Patients.
Study population-
Patients of POST OPERATIVE FISTULECTOMY WOUND fulfilling the inclusion criteria
Duration of study- 28 days
Follow up during study-
Day 0, Day 7, Day 14, Day 21 & 28 Day from the initiation of the study.
After permission of ICE and BORS- Prepared case record form will used. Informed consent from patients will be taken.
 
Close